1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Antibiotics Market: Product Outlook
4. Global Antibiotics Market: Size and Forecast
4.1 Global Antibiotics Market Size, By Value, 2016-2026
Table 1: Global Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 2: Number of children died from Tuberculosis, by region, 2019
Table 3: Cause of death in children under 5 years, 2018
Table 4: World Population 65 Years & Above (% of Total), 2015-2019
Table 5: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 6: Global Consumption of antibiotics in WHO countries, 2016 (In metric tonnes)
5. Global Antibiotics Market Segmentation By Drug Class, By Mechanism
5.1 Competitive Scenario of Global Antibiotics Market: By Drug Class
Table 7: Global Antibiotics Market- By Drug Class Market Share, 2020 & 2026
5.1.1 Beta-Lactams (Penicillin) Market Size and Forecast (2016-2026)
Table 8: Global Antibiotics Market- By Beta-Lactams (Penicillin) , By Value (USD Million), 2016-2026
5.1.2 Cephalosporins Market Size and Forecast (2016-2026)
Table 9: Global Antibiotics Market- By Cephalosporins, By Value (USD Million), 2016-2026
5.1.3 Lipopeptides Market Size and Forecast (2016-2026)
Table 10: Global Antibiotics Market- By Lipopeptides, By Value (USD Million), 2016-2026
5.1.4 Others Market Size and Forecast (2016-2026)
Table 11: Global Antibiotics Market- By Others, By Value (USD Million), 2016-2026
5.2 Competitive Scenario of Global Antibiotics Market: By Mechanism
Table 12: Global Antibiotics Market- By Mechanism Market Share, 2020 & 2026
5.2.1 Cell Wall Synthesis Market Size and Forecast (2016-2026)
Table 13: Global Antibiotics Market- By Cell Wall Synthesis, By Value (USD Million), 2016-2026
5.2.2 Protein Synthesis Market Size and Forecast (2016-2026)
Table 14: Global Antibiotics Market- By Protein Synthesis, By Value (USD Million), 2016-2026
5.2.3 DNA Synthesis Market Size and Forecast (2016-2026)
Table 15: Global Antibiotics Market- By DNA Synthesis, By Value (USD Million), 2016-2026
5.2.4 Others Market Size and Forecast (2016-2026)
Table 16: Global Antibiotics Market- By Others, By Value (USD Million), 2016-2026
6. Global Antibiotics Market: Regional Analysis
6.1 Competitive Scenario of Global Antibiotics Market: By Region
Table 17: Global Antibiotics Market- By Region Market Share, 2020 & 2026
7. North America Antibiotics Market: An Analysis (2016-2026)
7.1 North America Antibiotics Market: Size and Forecast (2016-2026)
Table 18: North America Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 19: North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 20: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 21: North America Urban population, 2015-2018 (In %)
7.2 North America Antibiotics Market Prominent Companies
Table 22: North America Antibiotic players market share (%), 2020
7.3 Market Segmentation By Drug Class (Beta-Lactams (Penicillin), Cephalosporins, Lipopeptides and Others)
Table 23: North America Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
7.4 Market Segmentation By Mechanism (Cell Wall Synthesis, Protein Synthesis, DNA Synthesis and Others)
Table 24: North America Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
7.5 North America Antibiotics Market: Country Analysis
7.6 Market Opportunity Chart of North America Antibiotics Market - By Country, By Value, 2026
Table 25: Market Opportunity Chart of North America Antibiotics Market- By Country, By Value (Year 2016-2026)
7.7 Competitive Scenario of North America Antibiotics Market: By Country
Table 26: North America Antibiotics Market- By Country Market Share, 2020 & 2026
7.8 United States Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 27: United States Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 28: United States year-on-year growth of antibiotics (in %), (2017-2026)
Table 29: United States population aged 65 and above, (in % of the total population), 2016-2020
Table 30: United States health expenditure (% of GDP), 2013-2018
7.9 United States Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 31: United States Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 32: United States Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
7.10 Canada Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 33: Canada Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 34: Canada population aged 65 and above (% of total population), 2016-2020
Table 35: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 36: Canada Urban population, 2015-2019 (In %)
7.11 Canada Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 37: Canada Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 38: Canada Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
8. Europe Antibiotics Market: An Analysis (2016-2026)
8.1 Europe Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 39: Europe Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 40: Europe current health expenditure (% of GDP), (2014-2018)
Table 41: Europe total consumption of antibiotics among countries (in metric tonnes), (2016)
Table 42: Europe median number of deaths due to antibiotic resistance bacteria, (2015)
8.2 Europe Antibiotics Market Prominent Companies
Table 43: Europe Antibiotic players market share (%), 2020
8.3 Market Segmentation By Drug Class (Beta-Lactams (Penicillin), Cephalosporins, Lipopeptides and Others)
Table 44: Europe Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
8.4 Market Segmentation By Mechanism (Cell Wall Synthesis, Protein Synthesis, DNA Synthesis and Others)
Table 45: Europe Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
8.5 Europe Antibiotics Market: Country Analysis
8.6 Market Opportunity Chart of Europe Antibiotics Market - By Country, By Value, 2026
Table 46: Market Opportunity Chart of Europe Antibiotics Market- By Country, By Value (Year 2016-2026)
8.7 Competitive Scenario of Europe Antibiotics Market: By Country
Table 47: Europe Antibiotics Market- By Country Market Share, 2020 & 2026
8.8 Germany Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 48: Germany Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 49: Germany current health expenditure (% of GDP), (2014-2018)
Table 50: Germany population aged 65 and above (% of the total population), 2016-2020
Table 51: Germany antimicrobial-resistant indicators (% of isolated tested), 2020
8.9 Germany Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 52: Germany Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 53: Germany Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
8.10 United Kingdom Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 54: United Kingdom Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 55: United Kingdom current health expenditure (% of GDP), (2014-2018)
Table 56: United Kingdom population aged 65 and above (% of total population), 2016-2020
Table 57: United Kingdom urban population (in millions), 2016-2020
8.11 United Kingdom Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 58: United Kingdom Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 59: United Kingdom Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
8.12 France Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 60: France Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 61: France current health expenditure (% of GDP), (2014-2018)
Table 62: France consumption of antibiotics (defined daily doses per 1000 inhabitants per day), 2012-2016
Table 63: France population aged 65 and above (% of total population), 2016-2020
8.13 France Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 64: France Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 65: France Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
8.14 Spain Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 66: Spain Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 67: Spain current health expenditure (% of GDP), (2014-2018)
Table 68: Spain population aged 65 and above (% of total population), 2016-2020
Table 69: Spain share of individuals consuming antibiotics, 2018
8.15 Spain Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 70: Spain Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 71: Spain Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
8.16 Italy Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 72: Italy Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 73: Italy current health expenditure (% of GDP), (2014-2018)
Table 74: Italy population aged 65 and above (% of total population), 2016-2020
Table 75: Italy antimicrobial-resistant indicators (% of isolated tests), 2020
8.17 Italy Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 76: Italy Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 77: Italy Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
9. Asia Pacific Antibiotics Market: An Analysis (2016-2026)
9.1 Asia Pacific Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 78: Asia Pacific Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 79: Asia Pacific antimicrobial use (daily defined doses in millions), 2020
Table 80: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 81: Asia Pacific Incidence of tuberculosis per 100,000 people, 2019
9.2 Asia Pacific Antibiotics Market Prominent Companies
9.3 Market Segmentation By Drug Class (Beta-Lactams (Penicillin), Cephalosporins, Lipopeptides and Others)
Table 82: Asia Pacific Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
9.4 Market Segmentation By Mechanism (Cell Wall Synthesis, Protein Synthesis, DNA Synthesis and Others)
Table 83: Asia Pacific Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
9.5 Asia Pacific Antibiotics Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Antibiotics Market - By Country, By Value, 2026
Table 84: Market Opportunity Chart of APAC Antibiotics Market- By Country, By Value (Year-2026)
9.7 Competitive Scenario of Asia Pacific Antibiotics Market: By Country
Table 85: APAC Antibiotics Market- By Country Market Share, 2020 & 2026
9.8 China Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 86: China Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 87: China total population in billions), 2016-2020
Table 88: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 89: China export of antibiotics to US, 2019, in USD Million
9.9 China Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 90: China Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 91: China Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
9.10 Japan Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 92: Japan Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 93: Japan population above 65 years (% of total population), 2016-2020
Table 94: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Table 95: Japan urban population (in millions), 2016-2020
9.11 Japan Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 96: Japan Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 97: Japan Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
9.12 India Antibiotics Market: Size and Forecast (2016-2026), By Value
Table 98: India Antibiotics Market Size, By Value, 2016-2026 (USD Million)
Table 99: India Current Healthcare Expenditure (% of GDP), 2015-2018
Table 100: India population (in billions), 2016-2020
Figure 101: India antimicrobial resistant indicators(% of isolated tested), 2020
9.13 India Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
Table 102: India Antibiotics Market- By Drug Class, By Value (USD Million), 2016-2026
Table 103: India Antibiotics Market- By Mechanism, By Value (USD Million), 2016-2026
10. Global Antibiotics Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Antibiotics Market By Drug Class, 2026
Table 104: Market Attractiveness Chart of Global Antibiotics Market- By Drug Class (Year-2016-2026)
11.2 Market Attractiveness Chart of Global Antibiotics Market - By Mechanism, 2026
Table 105: Market Attractiveness Chart of Global Antibiotics Market- By Mechanism (Year 2016-2026)
11.3 Market Attractiveness Chart of Global Antibiotics Market - By Region, 2026
Table 106: Market Attractiveness Chart of Global Antibiotics Market- By Region (Year 2016-2026)
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Product Pipeline of Leading Antibiotic Companies
Table A: Product Pipeline of Leading Antibiotic Companies DEINOVE
Table B: Clinical Pipeline of Antibiotics Development
Table C: Product Pipeline of Leading Antibiotics Companies
12.3 Market Share Analysis
Table 107: Global Antibiotic players market share (%), 2020
13. Company Analysis
13.1 DEINOVE
Table 108: DEINOVE Sales Revenues, 2016-2020 (USD Million)
Table 109: DEINOVE Loss, 2016-2020 (USD Million)
13.2 Bayer Group
Table 110: Bayer Group Sales Revenues, 2016-2020 (USD Million)
Table 111: Bayer Group Net Profit, 2016-2020 (USD Million)
Table 112: Bayer Group, By Business Segment (%), FY2020
Table 113: Bayer Group, By Geographical Segment (%), FY2020
13.3 Pfizer Inc.
Table 114: Pfizer Inc., Annual Sales Revenue (USD Million), 2016-2020
Table 115: Pfizer Inc., Annual Net Income/Loss (USD Million), 2016-2020
Table 116: Pfizer Inc., sales Revenue, By Geographical Segment (%), FY2020
13.4 GlaxoSmithKline
Table 117: GlaxoSmithKline Annual Sales Revenue (USD Million), 2016-2020
Table 118: GlaxoSmithKline Gross Profit (USD Million), 2016-2020
Table 119: GlaxoSmithKline Sales Revenue Split, By Business Segment (%), FY2020
Table 120: GlaxoSmithKline Sales Revenue Split, By Geography Segment (%), FY2020
13.5 Novartis AG, S.A.
Table 121: Novartis Annual Sales Revenue (USD Million), 2016-2020
Table 122: Novartis Annual Net Income/Loss (USD Million), 2016-2020
Table 123: Novartis Sales Revenue Split, By Business Segment (USD Million), FY2020
Table 124: Novartis Sales Revenue Split, By Geography Segment (%), FY2020
13.6 Eli Lily and Company
Table 125: Eli Lilly and Company Annual Sales Revenue (USD Million), 2016-2020
Table 126: Eli Lilly and Company Annual Net Income (USD Million), 2016-2020
Table 127: Eli Lilly and Company Sales Revenue Split, By Business Segment (USD Million), FY2020
Table 128: Eli Lilly and Company Sales Revenue Split, By Geography Segment (%), FY2020
13.7 Roche Holding AG
Table 129: Roche Holding AG Sales Revenues, 2016-2020 (USD Million)
Table 130: Roche Holding AG Net Income, 2016-2020 (USD Million)
Table 131 : Roche Holding AG sales Revenues, By Business Segment (%), FY2020
Table 132: Roche Holding AG sales Revenue, By Geographical Segment (%), FY2020
13.8 Amgen Inc.
Table 133: Amgen Inc. Sales Revenues, 2016-2020 (USD Million)
Table 134: Amgen Inc. Net Income, 2016-2020 (USD Million)
Table 135: Amgen Inc. Sales Revenue Split, By Business Segment (%), FY2020
Table 136: Amgen Inc. Sales Revenue Split, By Geography Segment (%), FY2020
13.9 Johnson & Johnson
Table 137: Johnson & Johnson Annual Sales Revenue (USD Billion), 2016-2020
Table 138: Johnson & Johnson Annual Net Income/Loss (USD Billion), 2016-2020
Table 139: Johnson & Johnson Sales Revenue Split, By Business Segment (%), FY2020
Figure 140: Johnson & Johnson Sales Revenue Split, By Geography Segment (%), FY2020
13.10 Merck KGaA
Table 141: Merck KGaA Sales Revenues, 2016-2020 (USD Million)
Table 142: Merck KGaA Gross Profit, 2016-2020 (USD Million)
Table 143: Merck KGaA Sales Revenue Split, By Business Segment (%), FY2020
Figure 144: Merck KGaA Sales Revenue Split, By Geography Segment (%), FY2020